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The invariant (Ii) chain is a membrane-spanning glycoprotein
found intracellularly associated with class II major histo-
compatibility complex (MHC) molecules. Using hybrid-
selected translation and the Ii-specific monoclonal antibody
In-1, we have isolated a cDNA clone (pli-5) coding for most
of the Ii chain. Sequence analysis of this clone reveals an open
reading frame encoding 169 amino acid residues. The protein
is rich in methionine and contains two potential N-glycosyla-
tion sites. No stretch of uncharged amino acid residues,
characteristic for a membrane-spanning segment, is found
close to the COOH-terminal end. There is one, however,
close to the NH2-terminal end. As it is known that -20
amino acid residues of Ii chain are exposed on the cyto-
plasmic side, we conclude that the Ii chain spans the mem-
brane exposing the NH2 terminus on the cytoplasmic side and
the COOH terminus on the luminal side.
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Expression of Ii chains is closely linked to that of Ia chains.
In certain cell lines Ii and Ia can be induced simultaneously by
,y interferon (Koch et al., 1984). Synthesis of Ii can be enhanc-
ed by the anti-mitotic drug mitomycin (Rahmsdorf et al.,
1983). However, the function of the Ii chain remains obscure.
The chain may play an as yet undefined physiological role in
the functioning of la molecules in the immune response, and
in intracellular transport of Ta chains (Sung and Jones, 1981;
Kvist et al., 1982b; McMillan et al., 1981). One way to test the
function of the Ii chain is to isolate the encoding gene and ex-
press it together with Ia molecules in appropriate cells, follow
its fate in the cell, and test the ability of these cells to present
antigen to T cells (Nagy et al., 1981). Here we describe the
isolation and characterization of a cDNA clone coding for the
Ii chain.
Results
In vitro synthesis of the Ii chain
For the selection of Ii cDNA clones by hybrid-selected trans-
lation it was necessary to characterize the Ii chain synthesized
in vitro. mRNA was therefore isolated from mouse spleens
(DBA/2 strain), a rich source of Ii and Ia polypeptides, and
translated in a reticulocyte lysate, cell-free translation system.
The Ii chain was immunoprecipitated with a previously
characterized monoclonal antibody (mAb) In-1, and analysed
by SDS-polyacrylamide gel electrophoresis (PAGE). The un-
processed Ii chain appears as a 25-kd protein, 6 kd smaller
than the mature Ii chain (Figure 1, cf. lanes 1 and 2). The dif-
ference in mol. wt. probably reflects the presence of two
Introduction
The invariant (Ii) chain is a membrane protein associated
intracellularly with class II major histocompatibility complex
(MHC) molecules called Ia in mouse and HLA-DR in human
(Klein, 1979; Benacerraf, 1981; Jones et al., 1978). These
molecules are involved in the presentation of foreign antigens
on macrophage-like cells and B cells to a particular subclass
of T cells (Benacerraf, 1981; Nagy et al., 1981). They consist
of an a chain non-covalently linked to a 3 chain. The Ii chain
is a methionine-rich glycoprotein containing two carbo-
hydrate side chains linked to asparagine (Sung and Jones,
1981; Charron et al., 1983; Moosic et al., 1980; Kvist et al.,
1982b; Swiedler, 1983; McMillan et al., 1981). It has a mol.
wt. of 31 K and is basic in character. Ii chains are synthesized
in excess over Ia and HLA-DR a and ,B chains and assemble
non-covalently with the latter in the membrane of the endo-
plasmic reticulum (ER) (Sung and Jones, 1981; Kvist et al.,
1982b). Intracellular transport of Ii chains from the ER to an
as yet undefined intracellular compartment requires assembly
with Ia a and , chains (Kvist et al., 1982b). However, no Ii
chain assembled with a and ,B chains can be detected on the
cell surface. Whether Ii chain alone can reach the cell surface
is still debated (Sung and Jones, 1981; Koch et al., 1982).
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Fig. 1. In vitro synthesis and membrane insertion of Ii chain. mRNA from
DBA/2 mouse spleens was translated in a reticulocyte lysate system in the
absence or presence of dog pancreas microsomes. Antigens were immuno-
precipitated with mAb In-I and characterized by SDS-PAGE and fluoro-
graphy. Lane 2 shows Ii chain synthesised in the absence of microsomal
membranes and lane 3 in the presence of microsomal membranes. For
comparison lane 1 shows antigens immunoprecipitated from
[35S]methionine-labeled mouse spleen cell with monoclonal anti Ia-A
monoclonal antibody 17/227 (Lemke et al., 1979).
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Fig. 2. Identification of a cDNA clone coding for Ii chain by hybrid-
selected translation. After an initial screening of pools of recombinant
plasmids constructed from spleen mRNA, DNA from one pool (number
11) selected mRNA coding for Ii chain. DNA from individual plasmids of
this pool was then used in hybrid-selected translation. Filter-bound mRNA
was translated in the reticulocyte lysate system and characterized by SDS-
PAGE. Lanes 1-4 show results with four of the plasmids, lane 5 with no
DNA bound to the filter. Antigens translated from hybrid-selected mRNAs
are displayed either directly (lanes a) or after immunoprecipitation with
mAb In-l (Koch et al., 1982) (lanes b). mRNA hybridized to plasmid DNA
used in lane 2 was further translated in the presence of microsomal
membrane and antigens immunoprecipitated with mAb In-I (lane 6) or
microsomal membranes were treated with proteinase K (lane 7) or
proteinase K and 0.5%o Triton X-100 (lane 8). The faint band at the
position of pIi in lanes lb, 3b, 4b and 5b is derived from mRNA
unspecifically adsorbed to the filter.
N-linked carbohydrate moieties in the mature Ii chain (Char-
ron et al., 1983; Swiedler et al., 1983). Indeed when micro-
somal membranes from dog pancreas, which are known to
support N-linked glycosylation, were added to the in vitro
translation system, a polypeptide of 31 kd was precipitated
with mAb In-I, indistinguishable from the form found in
cells after pulse-labeling (Figure 1, lane 3). To compare in
vitro synthesized Ii chain with Ii chain made in vivo, we label-
ed spleen cells for 15 min with [35S]methionine and immuno-
precipitated antigens with monoclonal antibody against Ia-
AO chains (Figure 1, lane 1). The Ii chain was found as a
polypeptide of 31 kd having an identical mol. wt. to the Ii
chain synthesized in vitro in the presence of dog pancreas
microsomes (compare Figure 1, lanes 1 and 3).
Identification of Ii chain cDNA clones by hybrid-selected
translation
Size-fractionated (12-16S) spleen mRNA was converted into
double-stranded cDNA and cloned into the PstI site of
pBR322 by the homopolymer tailing method. The trans-
formation yielded 1500 independent recombinants from one-
tenth of the culture that was plated directly onto agar plates.
For the initial screening, 240 of these clones were picked and
aliquots combined into 30 pools of eight clones each. Plasmid
DNA was prepared from the pools and immobilized on nitro-
cellulose filters for hybrid selection as described (Kvist et al.,
1982a). DNA from one of the pools (pool 11) selected spleen
mRNA which directed the translation of Ii chains as verified
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Fig. 3. Restriction map and sequencing strategy. Complementary DNA
clones, pli-I and pli-5, identified to code for Ii chain by hybrid-selected
translation or colony hybridization are oriented 3'-5' with respect to the
mRNA sequence. The coding region (solid bar), non-coding region (thin
line) and poly(A) sequences (AAA) are indicated. Restriction sites are BI,
Bgll, BII, BgIII; H, HinjI; Hi, HindIII; Hh, HhaI; P, PstI; Pv, PvuII; R,
RsaI; S, Sau3a; T, TaqI. Regions sequenced by the deletion subcloning
method (for clone pli-l) are indicated by the lower set of arrows. For clone
pli-5 restriction fragments were isolated and sequenced from either the
HindIII, BgllI or PvuII sites; upper strand sequencing (solid lines) lower
strand (broken lines).
by immunoprecipitation with the mAb In-I and SDS-PAGE
(data not shown).
Based on the above results, plasmid DNA from the in-
dividual clones in pool 11 was prepared and used for the
hybrid selection assay. Translation products from the
reticulocyte lysate system were characterized by SDS-PAGE
(Figure 2, lanes 1 -5), either directly (lanes a) or after
immunoprecipitation with mAb In-I (lanes b). In lane 2a the
25-kd unprocessed form of the Ii chain is seen clearly as the
major translation product and is specifically immuno-
precipitated with mAb In-I (lane 2b). The clone selecting this
mRNA was thus identified as containing the li-encoding
cDNA sequence, and was named pIi-I.
To characterize further the translated product, mRNA
selected by clone pIi-I was added to the reticulocyte lysate
system along with microsomal membranes. Figure 2, lane 6
shows that in the presence of microsomal membranes, a pro-
cessed 31-kd product, indistinguishable in mobility from in
vivo synthesized Ii chain is produced. When proteinase K is
used to digest the cytoplasmically exposed portion of this pro-
tein, a polypeptide - 2 kd smaller that the mature Ii chain was
found (Figure 2, lane 7). When the lipid bilayer of the micro-
somal vesicle was destroyed by Triton X-100, the protein was
completely digested (Figure 2, lane 8). These results are con-
sistent with those previously obtained for the human li-chain
identified functionally by its oligomeric assembly with HLA-
DR a and ( chains (Kvist et al., 1982b). They indicate that the
murine li-chain, like its human counterpart, is a trans-
membrane protein with a cytoplasmic tail of -2-3 kd in
size. Thus, we are confident that the clone pli-I contains a
cDNA sequence encoding the murine Ia-antigen-associated Ii-
chain.
Isolation andsequence analysis ofcDNA clonespIi-J andpIi-S
Clone pli-I was digested with PstI and a 920-bp fragment
containing the entire insert was isolated and used in a colony
hybridization experiment to probe 20 000 clones represen-
ting the remainder of the cDNA library. Eight clones were
identified and picked. Based on its restriction sites (Figure 3)
one of these clones, pli-5, had a significantly longer insert
than the others, and was analysed further.
Partial restriction maps of clones pli-I and pIi-5 are shown
in Figure 3. The inserts are -920 and 1170 bp in length,
respectively. Both are orientated in the same direction relative
to the vector; both have reconstituted PstI sites at each end,
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Gln Ala Thr Thr Ala Tyr Phe Leu Tyr Gln Gln Gln Gly Arg Leu Asp Lys Leu Thr Ile Thr Ser Gln Asn Leu
GAG GCC ACC ACT GCT TAC TTC CTG TAC CAG CAA CAG GGC CGC CTA GAC AAG CTG ACC ATC ACC TCC CAG AAC CTG
Gln Leu Glu Ser Leu Arg Met Lys Leu Pro Lys Ser Ala Lys Pro Val Ser Gln Met Arg Met Ala Thr Pro Leu
CAA CTG GAG AGC CTT CGC ATG AAG CTT CCG AAA TCT GCC AAA CCT GTG AGC CAG ATG CGG ATG GCT ACT CCC TTG
* *
Leu Met Arg Pro Met Ser Met Asp Asn Met Leu Leu Gly Pro Val Lys Asn Val Thr Lys Tyr Gly Asn Met Thr
CTG ATG CGT CCA ATG TCC ATG GAT AAC ATG CTC CTT GGG CCT GTG AAG AAC GTT ACC AAG TAC GGC AAC ATG ACC
Gln Asp His Val Met His Leu Leu Thr Arg Ser Gly Pro Leu Glu Tyr Pro Gln Leu Lys Gly Thr Phe Pro Glu
CAG GAC CAT GTG ATG CAT CTG CTC ACG AGG TCT GGA CCC CTG GAG TAC CCG CAG CTG AAG GGG ACC TTC CCA GAG
Asn Leu Lys His Leu Lys Asn Ser Met Asp Gly Val Asn Trp Lys Ile Phe Glu Ser Trp Met Lys Gln Trp Leu
AAT CTG AAG CAT CTT AAG AAC TCC ATG GAT GGC GTG AAC TGG AAG ATC TTC GAG AGC TGG ATG AAG CAG TGG CTC
Leu Phe Glu Met Ser Lys Asn Ser Leu Glu Glu Lys Lys Pro Thr Glu Ala Pro Pro Lys Glu Pro Leu Asp Met
TTG TTT GAG ATG AGC AAG AAC TCC CTG GAG GAG AAG AAG CCC ACC GAG GCT CCA CCT AAA GAG CCA CTG GAC ATG
Glu Asp Leu Ser Ser Gly Leu Gly Val Thr Arg Gln Glu Leu Gly Gln Val Thr Leu
GAA GAC CTA TCT TCT GGC CTG GGA GTG ACC AGG CAG GAA CTG GGT CAA GTC ACC CTG TGA AGACAGAGGCCAGCTCTGCA
GTGTCTGTTTCATCGTCCCAGGACACGGCAAATGAAGTCAGAACAGAAGGAGGACGCTGGAGGGCCTTGCTGGCACCGCATCTPAAGGGAACCCCCATTT
CCTTCTCCTCAAGGAAGAAGAACCCAA GCCCCTCCTCCCAGTAACCCCTCCTCACATCCTGCCACCCCCCCTCAAGCCCCACCCCCTTTCAGGTTCCTTG
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CTCAGCCAAGCTTGTCAGCAGCCTGTAGGATCATGGTTCAAGTGACAATAAAGGAMGAAAGTAGA -130 C z15 TGCA
Fig. 4. Nucleotide and deduced amino acid sequence of clone pli-5. The nucleotide sequence reveals one open reading frame encoding 169 amino acid
residues at the 5' end followed by 487 bases of 3' non-coding region and the poly(A) and oligo(C) tracks. Asterisks indicate the two potential glycosylation
sites.
no internal PstI sites, and identical cleavage sites for the in-
dicated restriction enzymes in the overlapping region. The
nucleotide sequence was determined from both clones as in-
dicated in Figure 3. The 3' non-coding region lies to the left
in the restriction map, with the start of the poly(A) tract posi-
tioned as indicated (Figure 3).
The complete coding region sequence of pIi-5 and the con-
sensus non-coding sequence are shown in Figure 4. All
regions comparable between the two clones were identical.
The only open reading frame defines a region (to the right on
the restriction map) encoding a sequence of 169 amino acid
residues. Judging from the apparent 25 K mol. wt. of the in
vitro synthesized, unprocessed Ii chain, the complete poly-
peptide chain should comprise -220 amino acid residues.
Thus, clone pli-5 appears to lack the sequence corresponding
to the amino-terminal 50 amino acid residues of the complete
Ii chain.
In the amino acid sequence predicted from clone pli-5, 13
residues are methionine (Figure 5), an unusually high
amount, but consistent with the known methionine-rich
nature of the Ii chain (Charron et al., 1983; McMillan et al.,
1981). In addition, two sites for N-linked glycosylation
(Asn66, Asn73) are clustered within a stretch of seven amino
acid residues near the middle of the polypeptide chain.
A surprising feature of the Ii chain sequence from pIi-5 is
the lack of hydrophobic, potential membrane-spanning seg-
ment near the carboxy-terminal end. Instead, there is a cluster
of charged residues present in this region (Figure 5). Protease
digestion of membrane-integrated human (Kvist et al., 1982b)
and murine Ii-chain (Lipp et al., in preparation, and see
Met
Arg, Lys
Glu, Asp
NH2 al lii
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1 10 50 100
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Fig. 5. Distribution of methionine and charged amino acid residues in Ii
chain deduced from cDNA clone pli-5. Positions of methionine, arginine
and lysine residues are indicated by a bar above the line, and glutamic acid
and aspartic acid residues by a bar below the line. The solid bar indicates a
stretch of uncharged amino acid residues.
Figure 2, lane 7) suggested that the chain is indeed a
membrane-spanning protein with 20-30 amino acid residues
exposed on the cytoplasmic side of the ER. Such a sequence
can only be located close to the amino-terminal end. In the
amino acid sequence predicted from pli-5 there is an un-
broken stretch of 13 uncharged residues at the amino-
terminal end (Figure 5), which might extend further to pro-
vide the usual stretch of 20-30 uncharged residues charac-
teristic of membrane-spanning segments (Warren, 1980). In-
deed, sequence data (not shown) from an Ii chain genomic
clone extending upstream from clone pli-5 do indicate an un-
broken stretch of 17 additional uncharged residues. This fin-
ding suggests that the Ii chain spans the membrane close to its
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cytoplasm
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Fig. 6. Proposed structure and membrane orientation of Ii chain. Our data
suggest that the Ii antigen spans the membrane close to the NHrterminal
end, exposing this end to the cytoplasm. It contains two carbohydrate side
chains linked to asparagine, six amino acid residues apart. Sequence data
are lacking from the region marked with diagonal lines.
amino-terminal end, exposing this end on the cytoplasmic
side.
Discussion
A cDNA clone coding for the murine Ii chain has been iden-
tified by the following criteria: (i) mRNA hybridized to clone
pli-I promoted translation of a 25-kd protein which could be
quantitatively precipitated by mAb In-1. This antibody has
previously been shown by Koch et al. (1982) to be specific for
Ii chain. (ii) Microsomes from dog pancreas converted this
25-kd form of Ii chain into a 31-kd glycosylated protein, iden-
tical in mol. wt. with the mature Ii chain. (iii) The 31-kd pro-
tein spans the membrane and exposes a 2-kd segment on the
cytoplasmic side. The same structural feature has previously
been found for human Ii chain (Kvist et al., 1982b) and
recently also for mouse Ii chain (Lipp et al., 1984). (iv) The
deduced amino acid sequence from clone pli-5 reveals that
the encoded protein is rich in methionine. At least eight
methionine-labeled tryptic peptides have been predicted for
authentic Ii chain (McMillan et al., 1981). We can identify 10
such tryptic peptides in the deduced sequence (Figure 4). (v)
Two potential N-linked carbohydrate binding sites are found
in the sequence and this is consistent with the number deter-
mined for authentic Ii chains (Charron et al., 1983; Swiedler
et al., 1983). Taken together these facts strongly suggest that
pli-5 codes for the Ia-associated Ii chain. Complementary
DNA coding for the human invariant chain has recently been
isolated by Long et al. (1983), however, no sequence data are
yet available.
Most membrane proteins thus far characterized span the
membrane close to the COOH-terminal end exposing this end
on the cytoplasmic side. For the following reasons we suggest
that Ii chain spans the membrane in the opposite orientation,
exposing the NH2-terminal end on the cytoplasmic side.
(i) The cluster of uncharged amino acid residues, typical for a
membrane-spanning segment, is not found close to the
COOH-terminal end (Warren, 1980). (ii) Our protection ex-
periments (Figure 2, lane 7) however, show that a segment of
- 20 amino acid residues is exposed on the cytoplasmic side.
(iii) A stretch of 30 uncharged amino acid residues is found
close to the NH2-terminal end. Thirteen of these residues have
been identified from clone pli-5 and 17 from a genomic clone
(Lauer et al., unpublished observation). (iv) Assuming a
length of -220 amino acid residues for the Ii chain, the
stretch of uncharged residues would be located 20 residues
away from the NH2 terminus.
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The only consistent conclusion from these data is that the
NH2 terminus of the Ii chain, comprising - 20 residues, is ex-
posed on the cytoplasmic side and is accessible in microsomal
vesicles to protease. A similar orientation has also been found
for the chicken hepatic lectin and the band 3 protein from
human erythrocyte (Drickamer, 1978, 1980).
The association of the Ii chain with Ia molecules has led to
the speculation that these chains might also be related struc-
turally. Finn et al. (1983) observed that a monoclonal anti-
body recognizing human Ia 3 chains showed some reactivity
with Ii chain. As the sequences for several Ia ai anda chain
genes or cDNAs are available (Benoist et al., 1983; Choi et
al., 1983; Larhammar et al., 1983; Malissen et al., 1983), we
used the program ALIGN to compare them with the sequence
of the Ii chain (Needleman and Wunsch, 1970). No statistical-
ly significant homology could be detected. This is not surpris-
ing, as many features of the Ii chain are very different from
those of Ia a and ( chains: opposite orientation in the mem-
brane, as well as the accumulation of charged and methionine
residues, and the lack of cysteine residues in the portion ex-
posed on the luminal side of the ER. Since, however, Ii chain
can form disulfide-linked homodimers, a cysteine residue
must exist on the cytoplasmic side (Koch and Hammerling,
1982). In Ia a and (3 chains intramolecular disulfide bridges
are found on the luminal side of the molecule.
The sequence characterization and the availability of a
cDNA clone coding for the Ii chain should help to elucidate
factors which determine the orientation of a protein in the
membrane and its final destination in an intracellular
organelle. They should also help to understand the role of Ii
chain in its association with Ia a and ( chains.
Materials and methods
The reticulocyte lysate was from New England Nuclear; guanidium thio-
cyanate from Fluka A.G.; oligo(dT)-cellulose from Collaborative Research;
terminal transferase from P-L Biochemicals; restriction endonucleases from
Boehringer or Bethesda Research Laboratory, and AMV reverse transcriptase
from Life Sciences, Inc.
mRNA isolation
Total cellular RNA was isolated from the spleens of - 100 C57BI/10 mice by
the guanidinium thiocyanate method as described by Chirgwin et al. (1979).
Poly(A)+ RNA was selected by two passages over oligo(dT)-cellulose, and
further fractionated on a 5 - 20%o sucrose gradient. Fractions corresponding
to 12- 16S RNA were pooled and ethanol-precipitated.
Protein synthesis and antibody precipitation
mRNA was translated in a reticulocyte lysate system supplemented, where in-
dicated, with dog pancreas microsomal membranes. Antigens were immuno-
precipitated as described (Kvist etal., 1982b). Antibodies used were mAb In-I
recognizing Ii chain (Koch et al., 1982) and mAb 17/227 recognizing a deter-
minant on the la-A chain (Lemke etal., 1979). For metabolic labeling, spleen
cells were incubated for 15 min with [35S]methionine. Proteins were then
solubilized with Triton X-100 and immunoprecipitated as described by Koch
et al. (1982), separated on 10-15%7o SDS-polyacrylamide slab gels (PAGE),
and visualized by fluorography using ENHANCE (New England Nuclear)
(Laemmli, 1970).
cDNA synthesis and cloning
Complementary DNA synthesis was carried out as described by Wahli et al.
(1978) using 10 Ag of 12-16S poly(A)+ RNA. Following SI-nuclease diges-
tion, the ds cDNA (0.2 jig) was dC-tailed in a 100 I1 reaction mixture contain-ing 0.1 M K+ cacodylate (pH 6.8), 1 mM CoCl2, 0.2 mM dithiothreitol,
250 pmol unlabeled dCTP (- 100-fold over 3' ends), 15 jICi [32P]dCTP (3000
Ci/nmol), and 100 units terminal transferase. After pre-warming the mixture
(5 min, 37°C), enzyme was added and the reaction allowed to proceed for
1 min before being stopped by the addition of EDTA to 20 mM, followed by
immediate phenol extraction. PstI-cleaved pBR322 was dG-tailed by the same
procedure, except that the 100 /1 reaction mixture contained 6.5 14g DNA(5 pmol 3'-ends), 500 pmol (5.8 tCi) [3H]dGTP, and the reaction was stop-
ped after 30 s.
Structure of murine Ia-associated invariant chain
The dC-tailed ds cDNA was fractionated on a 5- 20Wo sucrose gradient
and the high mol. wt. fractions (total of 0.1 pmol cDNA) were passed over
Sephadex G-50 equilibrated in TEN buffer (10 mM Tris-HCI, pH 7.4, 1 mM
EDTA, 100 mM NaCI). Annealing and transformation was done according
to Roewekamp and Firtel (1980). Complementary DNA from the G50
column was combined with 0.25 ug (0.1 pmol) dG-tailed vector DNA in
0.75 mlTEN buffer, heated to 63°C for 3 min, and allowed to anneal at 42°C
for 3 h followed by overnight incubation at room temperature. The annealing
mixture was transferred to ice, and diluted to 5 ml with ice-cold 30 mM CaCl2
before proceeding with the transformation protocol (Maniatis et al., 1982).
An aliquot (10%7o) of the final transformation culture was plated onto L-plates
and the remainder diluted 4-fold with fresh L-broth and allowed to grow
- 24 h. Plates and liquid medium contained tetracycline (15 yg/ml).
Plasmid DNA preparation
HBIOI cells harboring recombinant plasmids were grown as described by
Norgard et al. (1979), cleared lysate prepared (Bastia, 1978), and plasmid
DNA isolated by banding in CsCI,EtBr density gradients. Hybrid-selected
translation was done as described previously (Kvist et al., 1982a).
Colony hybridization
Bacterial colonies were grown on nitrocellulose filters, fixed and hybridized to
the nick-translated Pstl fragment of pli-I as described by Hanahan and
Meselson (1980).
DNA sequencing
All sequencing was done by the chemical method of Maxam and Gilbert
(1980). Subclones of clone pli-l were obtained for sequencing by the deletion
subcloning method (Frischauf et al., 1980).
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